XBiotech (XBIT) Earnings Analysis

XBiotech (XBIT) has no confirmed upcoming earnings date. Last quarter (2026-05-14) it missed with EPS -0.18 USD vs 0.03 USD est (-700%). It has beaten estimates in 0/2 recent quarters (0%). Trailing P/E -1.72.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does XBIT next report earnings?

No confirmed upcoming earnings date is currently scheduled for XBIT. This page updates as the calendar is published.

XBIT earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-14-0.18 USD0.03 USD-700%Miss
2026-03-13-0.88 USD0.04 USD-2300%Miss
2025-11-12-0.2 USDn/an/an/a
2025-08-13-0.06 USDn/an/an/a
2025-05-14-0.36 USDn/an/an/a
2025-03-18-0.34 USDn/an/an/a
2024-08-12-0.43 USDn/an/an/a

Beat rate: 0/2 (0%) over reported quarters with consensus data.

XBIT valuation and analyst view

Trailing P/E-1.72
Trailing EPS-1.31728 USD
Price / book0.51
Dividend yield0.00%
Market cap0.07B
Analyst consensusBuy (3 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is XBiotech (XBIT)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for XBIT. This page updates as the calendar is published.

Did XBIT beat earnings last quarter?

In its 2026-05-14 report, XBIT posted EPS of -0.18 USD versus a 0.03 USD estimate — a miss of 700%.

What is XBIT's earnings track record?

Over the last 2 reported quarters with consensus data, XBIT beat estimates 0 times (0%).

What is XBIT's current P/E ratio and EPS?

XBIT trades at a trailing P/E of -1.72 on trailing EPS of -1.3172839920425694 USD.

What do analysts rate XBIT?

Analyst consensus is "Buy" across 3 ratings (0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell).